相关实验视频

Updated: Jul 23, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

在B细胞淋巴瘤患者的化学抗原受体工程T细胞治疗中FDG-PET/CT成像:当前证据

Elisabetta Maria Abenavoli¹, Flavia Linguanti², Laurent Dercle³

¹Nuclear Medicine Unit, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, Italy.

|July 5, 2024

概括

用[18F]-FDG PET/CT进行正子发射断层扫描 (PET) 成像在治疗B细胞淋巴瘤的奇默抗原受体 (CAR) T细胞治疗的患者中起着至关重要的作用. 这篇评论强调了它的诊断,预后,预测和预后价值.

科学领域:

在瘤学瘤学.
核医学是一种核医学.
免疫治疗是一种免疫疗法.

背景情况:

化学抗原受体 (CAR) T细胞疗法是B细胞淋巴瘤耐药/复发的新疗法,已获得FDA和EMA等监管机构的批准.
监测治疗反应和潜在并发症对于优化患者护理至关重要.

研究的目的:

综合审查[18F]-FDG PET/CT成像在改善接受CAR T细胞治疗的患者护理方面的关键作用.
阐明 [18F]-FDG PET/CT成像中得出的参数的诊断,预后,预测和诊断价值. 在这个患者群体中.

主要方法:

对B细胞淋巴瘤的CAR T细胞疗法中[18F]-FDG PET/CT成像现有文献的系统综述.
分析诊断准确性,预后影响,预测能力和成像参数的预后应用.

主要成果:

[18F]-FDG PET/CT成像在评估治疗反应和检测复发方面具有显著的诊断价值.
[18F]-FDG PET/CT衍生参数提供有关患者结果的预后信息.
图像检测结果可以预测治疗的有效性,并指导治疗决策.
[18F]-FDG PET/CT具有潜在的治疗应用,集成诊断和治疗方面.

结论:

[18F]-FDG PET/CT成像是CAR T细胞治疗期间全面患者管理的必不可少的工具.
利用[18F]-FDG PET/CT衍生参数可以显著改善患者的治疗结果,并个性化B细胞淋巴瘤的治疗策略.

关键词:

不良事件是不良事件.在B细胞淋巴瘤.在CART-T中,我们可以使用CAR-T.德国联邦航空公司 (FDG)非霍奇金淋巴瘤非霍奇金淋巴瘤聚乙烯/聚乙烯/聚乙烯响应响应响应响应

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET